Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Oliver Henke"'
Autor:
Faryal M. Raza, Elifuraha W. Mkwizu, Steven A. Leak, Abid M. Sadiq, Furaha S. Lyamuya, Nyasatu G. Chamba, Kajiru G. Kilonzo, Elichilia R. Shao, Eijaaz A. Ahmed, Eliasa K. Ndale, Andrew R. Costantine, Eugenie M. Kamabu, Doreen T. Eliah, Eliada B. Nziku, Oliver Henke
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThis study sought to delineate the clinical, laboratory, and imaging characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities administered, and ascertain the survival rates among patients with MM over a comprehe
Externí odkaz:
https://doaj.org/article/84d927b880f14b98835dfcec5fde3b3c
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/adb782714b4c44e59788e4148a6b6159
Autor:
Alex Mremi, Marianne Gnanamuttupulle, Shilanaiman Hilary Ntundu, Oliver Henke, Kondo Chilonga, David Msuya
Publikováno v:
Clinical Case Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Key Clinical Message Describes a rare form of invasive breast cancer of no special type. Not a distinct morphological subtype. Characterized by dense lymphoid infiltrate, syncytial growth, pushing borders, and cells with high‐grade nuclei. Clinical
Externí odkaz:
https://doaj.org/article/4925d0f1cec8453fa33a6504db1354d7
Autor:
Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 949-953 (2022)
Abstract In this analysis, we examined the risk of secondary malignancies for tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia (CML) patients. We also collected data on specific risk factors for colorectal cancer. Ninety‐one pati
Externí odkaz:
https://doaj.org/article/54f065c65b1b4468aa13636b34af3f54
Autor:
Oliver Henke, India Pumphrey, Furaha Serventi, Atukuzwe Kahakwa, Anna Massawe, Antje Annaliese Henke
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Objective To ascertain how the COVID-19 pandemic was perceived by oncology patients and community health workers (CHWs) and whether this contributed to disruptions in cancer care.Design Cross-sectional study using (1) structured telephone interviews
Externí odkaz:
https://doaj.org/article/9268db9268244c4c83aa5d7915178824
Publikováno v:
BMJ Global Health, Vol 8, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/134cb51eebfe4a798e2079def0baf6b5
Autor:
Tara J. Rick, Magdeline Aagard, Erica Erwin, Caara Leintz, Elizabeth Danik, Furaha Serventi, Oliver Henke, Karen Yeates
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1500-1508 (2021)
PURPOSECancer is a growing problem in Africa, and delays in receiving timely cancer care often results in poorer outcomes. The purpose of this study was to identify the patient and health-system factors associated with delayed cancer care in adults l
Externí odkaz:
https://doaj.org/article/4bf651764202410a8092fd52c44a33df
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEIn Tanzania, patients with cancer present late with advanced stages. Among other reasons, the use of herbal medicine (HM) might contribute to delay in diagnosis and treatment. This study aims to understand the utilization of HM and the reasons
Externí odkaz:
https://doaj.org/article/eff37af9e98549ed9121eab11d037d79
Publikováno v:
HemaSphere, Vol 6, Pp 40-41 (2022)
Externí odkaz:
https://doaj.org/article/278426a867d7493f869695d75ee404d4
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-8 (2019)
PURPOSE: Cancer is a growing public health concern in low-income countries (LICs). From 14 million new patient cases identified worldwide each year, 8 million are diagnosed in LICs. The fatality rate is 75% in LICs compared with 46% in high-income co
Externí odkaz:
https://doaj.org/article/a67588703d9f469b90010f0d6a3ec4fb